Prof. Dr. Yosri Akl’s career is rooted in Cairo University’s Faculty of Medicine and the clinical tradition of Kasr Al Ainy. His professional record identifies him as founder of the Interstitial Lung Disease Unit at Kasr Al Ainy, while Cairo University continues to list him among its professors of pulmonary medicine.
Foundations of a pulmonary career
The available professional record does not establish a complete year-by-year account of Dr. Akl’s medical education and earliest academic appointments. For that reason, this biography begins its dated chronology in 1999 and presents earlier qualifications and roles only where the record supports them.
His professional CV identifies him as founder of the Interstitial Lung Disease Unit at Kasr Al Ainy, anchoring a specialist focus that is reflected repeatedly in his later clinical appointments, research and teaching.
Method: where an exact date is not established by the available record, the site does not assign one.
Building a specialist career
By 1999, Dr. Akl was leading the pulmonology unit at Cairo University’s National Institute of Laser Science, a role he held through 2006. In April 2007, his professional record dates his appointment as Professor of Pulmonary and Critical Care Medicine at the Faculty of Medicine, Cairo University.
The CV fills in the clinical architecture around those dates. It records leadership of the Unit of Diffuse Parenchymal Lung Diseases; consultant work in fiberoptic bronchoscopy and medical thoracoscopy; pulmonary physiology and pulmonary critical care; and consultant pulmonary medicine at New Kasr Al Ainy Teaching Hospitals.
His professional record also documents senior pulmonary appointments at the National Institute for Asthma and Chest Diseases, Dar Al Fouad Hospital, Police Hospitals, Shaalan Health System and Al-Shorouk Hospital.
From March 2011 to March 2012, he served as Director of the National Institute for Asthma and Chest Diseases. His professional record also lists service as General Secretary of the Egyptian Society of Chest and Allergy (ESCA), adding professional-society leadership to his academic and hospital responsibilities.
Questions carried into the literature
His publication trail is not confined to one phase of his career. The earliest publication currently indexed is from 2010, although that multicentre mesothelioma study analysed cases collected from 1998 through 2007 — evidence that the clinical and research record reaches further back than its publication date without proving a specific appointment in 1998.
Earlier work includes pleural disease and mesothelioma, followed by lung-cancer profiling, interventional bronchoscopy and a growing body of work around diffuse parenchymal and interstitial lung disease. From 2017 onward, hypersensitivity pneumonitis becomes especially visible across epidemiology, multidisciplinary diagnosis, histopathology, bronchoalveolar lavage and treatment research.
His professional record also includes an American Thoracic Society demographic study of hypersensitivity pneumonitis in Egypt, work on fiberoptic bronchoscopy in patients with hematological malignancies, and a review of sleep-disordered breathing in interstitial lung disease.
That work continues into the present. In 2025, he was first author on research examining antifibrotics in post-COVID lung sequelae and on a Scientific Reports study of rituximab in treatment-refractory hypersensitivity pneumonitis. In 2026, his name appears on a systematic review and meta-analysis of therapies beyond corticosteroids for hypersensitivity pneumonitis and on further pulmonary research now indexed in the Research section.
Explore the research archive →Institutions, departments and teams
The surviving department-chair record is more layered than a single start date. Public coverage already describes Dr. Akl as Head of the Chest Diseases Department in 2020 and 2021. A September 2022 Cairo University appointment decision then names him to the department chair, which may represent an appointment or reappointment. The archive therefore preserves that evidence without claiming a first start date that has not yet been recovered.
His leadership is repeatedly documented through 2024 and 2025. At the department’s annual conference in December 2024, Cairo University announced the diagnosis of what it described as Egypt’s first case of VEXAS syndrome by a specialist team under the department’s leadership.
In November 2025, the Faculty of Medicine documented the department’s Scientific Day under his supervision. On 14 January 2026, Cairo University publicly thanked him after the completion of his chairmanship, crediting his tenure with contributions to the department’s academic and research development and with strengthening its standing internally and externally.
A career still active
Alongside formal academic work, Dr. Akl has appeared in public-facing medical education. Nile University hosted him in 2020 for a webinar on COVID-19 in Egypt, while later interviews and discussions document his public voice on respiratory medicine and complex disease.
Recent publications and institutional records show a professional life that continues beyond department chairmanship, with research and public medical communication remaining part of the record through 2026.
This biography draws on institutional records, journal and conference records, public media, and Dr. Akl’s professional CV. Where an exact date is not established by the available evidence, the site avoids assigning one.
Professional CV · biographical source Cairo University · Chest Department roster ↗ Nile University · professional biography & webinar record ↗ Cairo University · 2024 conference & VEXAS announcement ↗ Cairo University · 2026 recognition and chair transition ↗